Agenda

Return

C. 67

To:	Board of Supervisors
From:	Anna Roth, Health Services Director
Date:	April 18, 2023

Contra

Costa

County

Subject:

Purchase Order with CDPH Genetic Disease Screening Program

APPROVE	OTHER
RECOMMENDATION OF CNTY ADMINISTRATOR	RECOMMENDATION OF BOARD COMMITTEE

Action of Board On: 04/18/2023

APPROVED AS RECOMMENDED

OTHER

Clerks Notes:

VOTE OF SUPERVISORS

AYE:

Candace Andersen, District II Supervisor
Diane Burgis, District III Supervisor
Ken Carlson, District IV Supervisor
Federal D. Glover, District V Supervisor

ABSENT:

John Gioia, District I Supervisor

Contact:

Sam Ferrell, (925) 357-7483

I hereby certify that this is a true and correct copy of an action taken and entered on the minutes of the Board of Supervisors on the date shown.
ATTESTED: April 18, 2023
Monica Nino, County Administrator

BY:	, Deputy

RECOMMENDATION(S):

APPROVE and AUTHORIZE the Purchasing Agent, or designee, to execute on behalf of the Health Services Director, a purchase order with the CDPH Genetic Disease Screening Program in an amount not to exceed $1,000,000 for newborn genetic screening tests performed at Contra Costa Regional Medical Center (CCRMC), for the period from July 1, 2023 through June 30, 2026.

FISCAL IMPACT:

Approval of this action will result in expenditures of up to $1,000,000 over a three-year period and will be funded by the Hospital Enterprise Fund I revenues.

BACKGROUND:

The California Newborn Screening Program (NBS) is a public health program that screens all babies for eighty (80) disorders, both genetic and congenital. All babies born in the State of California are required to be screened after birth. The goal of the program is to identify babies with these disorders early, in order to provide treatment right away. The newborn screening is completed by taking a sample of the newborn’s blood within twelve (12) to forty-eight (48) hours of life. California Health and Safety Code 125000 regulates that all hospitals provide Genetic Screening Program testing. Billing is directed by CDPH which provides accreditation for CCRMC and the Clinical Laboratory.

On August 16, 2022, the Board of Supervisors approved agenda item C.37 to execute a purchase order (26277) with the CDPH Genetic Disease Screening Program in an amount not exceed $325,000 for newborn genetic screening tests performed at Contra Costa Regional Medical Center (CCRMC), for the period of July 1, 2022 through June 30, 2023.

Approval of the requested purchase order will support CCRMC’s ability to continue compliance with the requirements and goals of the NBS Program and allow CDPH to continue providing newborn genetic screening tests to CCRMC through June 30, 2026.

CONSEQUENCE OF NEGATIVE ACTION:

If this action is not approved, CCRMC would not be able to pay for genetic testing of newborns and would not be in compliance with the State of California.